Strategies for Addressing Health Disparities in Medication Assisted Treatment (MAT) for Opioid Use Disorders Webinar

Posted 6/2/2021 (updated 6/17/2021)

According to the Centers for Disease Control and Prevention (CDC), African American/Black communities have been disproportionately affected by opioid use disorders (OUDs) and overdose deaths, yet the availability of treatment and recovery services, including the full range of medications for opioid use disorder (medication-assisted treatment, or MAT) may be far less available to them and other racial/ethnic/linguistic minority groups. This webinar will focus on understanding these health disparities and will outline strategies to enhance access to all treatment services, including buprenorphine and naloxone along with methadone. The webinar will briefly review the physiology/neurobiology of opioid use disorder, the evidence in support of MAT, and how MAT fits within an integrated care model.